Development of a classifier to identify patients with probable Lennox–Gastaut syndrome in health insurance claims databases via random forest methodology

References

• Bourgeois BF, Douglass LM, Sankar R. Lennox–Gastaut syndrome: a consensus approach to differential diagnosis. Epilepsia. 2014;55:4–9.
   PubMed Web of Science ®Google Scholar
• Hancock EC, Cross JH. Treatment of Lennox–Gastaut syndrome. Cochrane Database Syst Rev. 2013;2:CD003277.
   PubMed Web of Science ®Google Scholar
• Camfield PR. Definition and natural history of Lennox–Gastaut syndrome. Epilepsia. 2011;52:3–9.
   PubMed Web of Science ®Google Scholar
• Arzimanoglou A, French J, Blume WT, et al. Lennox–Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82–93.
   PubMed Web of Science ®Google Scholar
• Ferlazzo E, Nikaronova M, Italiano D, et al. Lennox–Gastaut syndrome in adulthood: clinical and EEG features. Epilepsy Res. 2010;89:271–277.
   PubMed Web of Science ®Google Scholar
• Ogawa K, Kanemoto K, Ishii Y, et al. Long-term follow-up study of Lennox–Gastaut syndrome in patients with severe motor and intellectual disabilities: with special reference to the problem of dysphagia. Seizure. 2001;10:197–202.
   PubMed Web of Science ®Google Scholar
• Oguni H, Hayashi K, Osawa M. Long-term prognosis of Lennox–Gastaut syndrome. Epilepsia. 1996;37:44–47.
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Amano R, Mizukawa M, et al. Long-term prognosis of the Lennox–Gastaut syndrome. Jpn J Psychiatry Neurol. 1990;44:257–264.
   PubMedGoogle Scholar
• Pina-Garza JE, Chung S, Montouris GD, et al. Challenges in identifying Lennox–Gastaut syndrome in adults: a case series illustrating its changing nature. Epilepsy Behav Case Rep. 2016;5:38–43.
   PubMed Web of Science ®Google Scholar
• Yagi K. Evolution of Lennox–Gastaut syndrome: a long-term longitudinal study. Epilepsia. 1996;37:48–51.
   PubMed Web of Science ®Google Scholar
• Glauser TA. Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia. 2004;45:23–26.
   PubMed Web of Science ®Google Scholar
• Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007;48:1128–1132.
   PubMed Web of Science ®Google Scholar
• Autry AR, Trevathan E, Van Naarden Braun K, et al. Increased risk of death among children with Lennox–Gastaut syndrome and infantile spasms. J Child Neurol. 2010;25:441–447.
   PubMed Web of Science ®Google Scholar
• Arzimanoglou A, Resnick T. All children who experience epileptic falls do not necessarily have Lennox–Gastaut syndrome…but many do. Epileptic Disord. 2011;13:S3–S13.
   PubMed Web of Science ®Google Scholar
• Skornicki M, Clements KM, O’Sullivan AK. Budget impact analysis of antiepileptic drugs for Lennox–Gastaut syndrome. J Manag Care Spec Pharm. 2014;20:400–406.
   PubMed Web of Science ®Google Scholar
• Nilsson L, Farahmand BY, Persson PG, et al. Risk factors for sudden unexpected death in epilepsy: a case–control study. Lancet. 1999;353:888–893.
   PubMed Web of Science ®Google Scholar
• Clements KM, Skornicki M, O’Sullivan AK. Cost–effectiveness analysis of antiepileptic drugs in the treatment of Lennox–Gastaut syndrome. Epilepsy Behav. 2013;29:184–189.
   PubMed Web of Science ®Google Scholar
• Berry JG, Poduri A, Bonkowsky JL, et al. Trends in resource utilization by children with neurological impairment in the United States inpatient health care system: a repeat cross-sectional study. PLoS Med. 2012;9:e1001158.
   PubMed Web of Science ®Google Scholar
• Standridge SM, Horn PS. Variations in hospitalization outcomes in children admitted with seizures between 2003 and 2006. J Child Neurol. 2012;27:898–906.
   PubMed Web of Science ®Google Scholar
• Camfield C, Camfield P. Twenty years after childhood-onset symptomatic generalized epilepsy the social outcome is usually dependency or death: a population-based study. Dev Med Child Neurol. 2008;50:859–863.
   PubMed Web of Science ®Google Scholar
• Camfield PR, Gibson PA, Douglass LM. Strategies for transitioning to adult care for youth with Lennox–Gastaut syndrome and related disorders. Epilepsia. 2011;52:21–27.
   PubMed Web of Science ®Google Scholar
• The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) [Internet] [cited 2019 Feb 12]. Available from: https://www.cdc.gov/nchs/icd/icd10cm.htm
   Google Scholar
• National Center for Health Statistics. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) [Internet] [cited 2019 Feb 12]. Available from: http://www.cdc.gov/nchs/icd/icd9cm.htm
   Google Scholar
• Benedict A, Verdian L, Maclaine G. The cost effectiveness of rufinamide in the treatment of Lennox–Gastaut syndrome in the UK. Pharmacoeconomics. 2010;28:185–199.
   PubMed Web of Science ®Google Scholar
• Verdian L, Yi Y. Cost–utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox–Gastaut Syndrome in the United Kingdom. Seizure. 2010;19:1–11.
   PubMed Web of Science ®Google Scholar
• Stern JM, François C, Ogbonnaya A, et al. Changes in healthcare resource utilization among Medicaid patients with Lennox–Gastaut Syndrome initiating clobazam treatment. Neurology. 2016;86(suppl):P1.064.
   Google Scholar
• Khalilia M, Chakraborty S, Popescu M. Predicting disease risks from highly imbalanced data using random forest. BMC Med Inform Decis Mak. 2011;11:51.
   PubMed Web of Science ®Google Scholar
• Liaw A, Wiener M. Classification and regression by random forest. R News. 2002;2:18–22.
   Google Scholar
• Brieman L. Random forests. Machine Learning. 2001;45:5–32.
   Web of Science ®Google Scholar
• Brieman L. Manual – setting up, using, and understanding random forests v4.0 [Internet] [cited 2019 Feb 12]. Available from: https://www.stat.berkeley.edu/∼breiman/Using_random_forests_v4.0.pdf
   Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiving operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
   PubMed Web of Science ®Google Scholar
• Peng SY, Chuang YC, Kang TW, et al. Random forest can predict 30-day mortality of spontaneous intracerebral hemorrhage with remarkable discrimination. Eur J Neurol. 2010;17:945–950.
   PubMed Web of Science ®Google Scholar
• Azar AT, Elshazly HI, Hassanien AE, et al. A random forest classifier for lymph diseases. Comput Methods Programs Biomed. 2014;113:465–473.
   PubMed Web of Science ®Google Scholar
• DuBrava S, Mardekian J, Sadosky A, et al. Using random forest models to identify correlates of a diabetic peripheral neuropathy diagnosis from electronic health record data. Pain Med. 2017;18:107–115.
   PubMed Web of Science ®Google Scholar
• Masetic Z, Subasi A. Congestive heart failure detection using random forest classifier. Comput Methods Programs Biomed. 2016;130:54–64.
   PubMed Web of Science ®Google Scholar
• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58:512–521.
   PubMed Web of Science ®Google Scholar
• Pina-Garza JE, Montouris GD, Vekeman F, et al. Assessment of treatment patterns and healthcare costs associated with probable Lennox–Gastaut syndrome. Epilepsy Behav. 2017;73:46–50.
   PubMed Web of Science ®Google Scholar